Random assignment turned medicine into a fair fight
Patients differ in ways no checklist can catch. Randomized controlled trials shuffle people into treatment and comparison arms so bias and confounders lose their grip. A 1948 streptomycin study helped invent the modern gold standard—and ethics still argue over placebos and consent.
An RCT is a statistical experiment that tests whether an intervention works or is safe by randomly allocating participants to comparison groups. At least one arm gets the studied process—drug, surgery, device, diet—while others get an alternative, placebo, or usual care. Many call well-run RCTs among the strongest evidence in evidence-based medicine because they curb selection bias and confounding, though critics note they do not always erase bias.
Randomization balances known and unknown prognostic factors; blinding, ideally for participants and investigators alike, separates physiology from psychology. Clinical RCTs often pit a new experimental treatment against standard care, or against placebo when no accepted care exists. Austin Bradford Hill is credited with conceiving the modern RCT; the first published medical example was the 1948 Medical Research Council paper on streptomycin for pulmonary tuberculosis. By 2004 the Cochrane Library held more than 150,000 RCTs, and CONSORT guidelines from 1996 onward pressed for clearer reporting.
Earlier threads run deep: Jan Baptist van Helmont proposed a fever trial in Ortus Medicinae of 1648; James Lind ran a scurvy trial in 1747; the French Royal Commission blinded mesmerism tests in 1784. Psychology saw randomized experiments with Peirce and Jastrow in the 1880s; agriculture felt Fisher and Neyman. Design types include parallel-group, crossover, cluster, factorial, and stepped-wedge. A PubMed snapshot from December 2006 found 78 percent of 616 RCTs were parallel-group.
Ethics bite hard. Placebo controls can be wrong when withholding care risks harm. Therapeutic misconception leaves some subjects thinking research guarantees personal best care. Equipoise—genuine expert uncertainty—can clash with personal belief. Still, proper randomization eliminates assignment bias and aids masking, which is why a well-blinded RCT remains the clinical gold standard for causal claims about human health.
Source: Randomized controlled trial
